The NanoMicS project will focus on lipidic nanoparticles, produced with the Microfluidizer® Technology. They allowing an efficient #encapsulation of low soluble APIs in digestive fluids and a significant improvement of their passage into the blood, thanks to their surface properties.
All informations on
https://www.linkedin.com/feed/update/urn:li:activity:6760829151483072512
Filed under: NewsTagged with: Gepharm
